01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

Giovannangeli C, Perrouault L, Escude C, Gryaznov S, Hélène C
(1996) Efficient inhibition of transcription elongation in vitro
by oligonucleotide phosphoramidates targeted to proviral
HIV DNA. J Mol Biol 261, 386-398.
Goldman CK, Soroceanu L, Smith N, Gillespie GY, Shaw W,
Burgess S, Bilbao G, Curiel DT (1997) In vitro and in vivo
gene delivery mediated by a synthetic polycationic amino
polymer. Nat Biotechnol 15, 462-466.
Good PD, Krikos AJ, Li SX, Bertrand E, Lee NS, Giver L,
Ellington A, Zaia JA, Rossi JJ, Engelke DR (1997)
Expression of small, therapeutic RNAs in human cell nuclei.
Gene Ther 4, 45-54.
Gorman CM, Aikawa M, Fox B, Fox E, Lapuz C, Michaud B,
Nguyen H, Roche E, Sawa T, Wiener-Kronish JP (1997)
Efficient in vivo delivery of DNA to pulmonary cells using
the novel lipid EDMPC. Gene Ther 4, 983-992.
Gottesman MM amd Pastan I (1988) The multidrug transporter, a
double-edged sword. J Biol Chem 263, 12163-12166.
Gottfredsson M, Bohjanen PR (1997) Human immunodeficiency
virus type I as a target for gene therapy. Front Biosci 2,
D619-D634.
Gottschalk S, Christiano RJ, Smith LC, and Woo SLC (1993)
Folate receptor mediated DNA delivery into tumor cells:
Potosomal disruption results in enhanced gene expression.
Gene Ther 1, 185-191.
Gözükara EM, Parris CN, Weber CA, Salazar EP, Seidman MM,
Watkins JF, Prakash L , Kraemer KH (1994) The human
DNA repair gene, ERCC2 (XPD), corrects ultraviolet
hypersensitivity and ultraviolet hypermutability of a shuttle
vector replicated in xeroderma pigmentosum group D cells.
Cancer Res 54, 3837-3844.
Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ,
Lowe SW, and Giaccia AJ (1996) Hypoxia-mediated
selection of cells with diminished apoptotic potential in solid
tumours. Nature 379, 88-91.
Graham RA, Burchell JM, Beverley P, Taylor-Papadimitriou J
(1996) Intramuscular immunisation with MUC1 cDNA can
protect C57 mice challenged with MUC1-expressing
syngeneic mouse tumour cells. Int J Cancer 65, 664-670.
Greber UF, Webster P, Weber J, and Helenius A (1996) The role
of the adenovirus protease in virus entry into cells. EMBO J
15, 1766-1777.
Green NK, Youngs DJ, Neoptolemos JP, Friedlos F, Knox RJ,
Springer CJ, Anlezark GM, Michael NP, Melton RG, Ford
MJ, Young LS, Kerr DJ, Searle PF (1997) Sensitization of
colorectal and pancreatic cancer cell lines to the prodrug 5-
(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral
transduction and expression of the E. coli nitroreductase
gene. Cancer Gene Ther 4, 229-238.
Grossman M, Rader DJ, Muller DW, Kolansky DM, Kozarsky
K, Clark BJ 3rd, Stein EA, Lupien PJ, Brewer HB Jr, Raper
SE, et al (1995) A pilot study of ex vivo gene therapy for
homozygous familial hypercholesterolaemia. Nat Med 1,
1148-1154.
Grossman M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF,
Muller D, Lupien PJ, Wilson JM (1994) Successful ex vivo
gene therapy directed to liver in a patient with familial
hypercholesterolaemia. Nat Genet 6, 335-341.
Gene Therapy and Molecular Biology Vol 1, page 141
141
Grossman M, Raper SE, Wilson JM (1992) Transplantation of
genetically modified autologous hepatocytes into nonhuman
primates: feasibility and short-term toxicity. Hum Gene
Ther 3, 501-510.
Guieysse AL, Praseuth D, Hélène C (1997) Identification of a
triplex DNA-binding protein from human cells. J Mol Biol
267, 289-298.
Gunzburg WH, Salmons B (1996) Development of retroviral
vectors as safe, targeted gene delivery systems. J Mol Med
74, 171-182.
Guo ZS, Wang LH, Eisensmith RC, Woo SL (1996) Evaluation
of promoter strength for hepatic gene expression in vivo
following adenovirus-mediated gene transfer. Gene Ther 3,
802-810.
Guzman RJ, Hirskowitz EA, Brody SL, Crystal RG, Epstein SE,
and Finkel T (1994) In vivo suppression of injury-induced
vascular smooth muscle cell accumulation using adenovirusmediated
transfer of the herpes simplex virus thymidine
kinase gene. Proc Natl Acad Sci USA 91, 10732-10736.
Haffe HA, Danel C, Longenecker G, Metzger M, Setoguchi Y et
al, (1992) Adenovirus-mediated in vivo gene transfer and
expression in normal rat liver. Nature Genet 1, 372-378.
Haj-Ahmad Y and Graham FL (1986) Development of a helperindependent
human adenovirus vector and its use in the
transfer of the herpes simplex virus thymidine kinase gene. J
Virol 57, 267-274.
Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA,
Friedman JM (1997) Physiological response to long-term
peripheral and central leptin infusion in lean and obese mice.
Proc Natl Acad Sci USA 94, 8878-8883.
Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT,
Rabinowitz D, Lallone RL, Burley SK, Friedman JM (1995)
Weight-reducing effects of the plasma protein encoded by
the obese gene. Science 269, 543-546.
Halbert CL, Standaert TA, Aitken ML, Alexander IE, Russell
DW, Miller AD (1997) Transduction by adeno-associated
virus vectors in the rabbit airway: efficiency, persistence, and
readministration. J Virol 71, 5932-5941.
Haluska, F.G., Tsujimoto, Y. and Croce, C.M. (1987) Oncogene
activation by chromosome translocation in human
malignancy. Annu. Rev. Genetics 21, 321-347.
Hammes H-P, Brownlee M, Jonczyk A, Sutter A, Preissner KT
(1995) Subcutaneous injection of a cyclic peptide antagonist
of vitronectin receptor-type integrins inhibits retinal
neovascularization. Nature Med 2, 529-533.
Hamouda T, McPhee R, Hsia SC, Read GS, Holland TC, King
SR (1997) Inhibition of human immunodeficiency virus
replication by the herpes simplex virus virion host shutoff
protein. Virol 71, 5521-5527.
Han J, Sabbatini P, Perez D, Rao L, Modha D, and White E
(1996) The E1B 19K protein blocks apoptosis by interacting
with and inhibiting the p53-inducible and death-promoting
Bax protein. Genes Dev 10, 461-477.
Hanazono Y, Yu JM, Dunbar CE, Emmons RV (1997) Green
fluorescent protein retroviral vectors: low titer and high
recombination frequency suggest a selective disadvantage.
Hum Gene Ther 8, 1313-1319.